Advocacy

FLCCC Executive Director, Kelly Bumann joins Dr. Pierre Kory and host Betsy Ashton to look back on 2022 and talk about the year ahead.

Bernadette Pajer helped ignite one of the most potent legislative victories over regulatory capture that we have seen in recent years.

Dr. Fauci’s career is a clear demonstration of what many fear most from our government: ego-driven technocrats pushing a failing, evidence-free political agenda on the country with no transparency or accountability.

FLCCC mourns the loss of Dr. Vladimir Zelenko, fierce advocate for early COVID treatment The entire team at FLCCC is saddened to hear of the loss of a great friend and fellow supporter of early treatment for COVID-19. We extend our deepest condolences and sympathies to the Zelenko family and pray they find the strength to see them through this difficult time. “Dr. Zelenko stepped up and fought for access to early treatment when few others did,” said Dr. Pierre Kory, President and Chief Medical Officer of FLCCC. “He had a huge impact, and his loss will be felt by many.”

ACTIV-6 severely limited the use of ivermectin, administering a dose below what is known to be effective on the variants at the time and received too late (6 days on average) after the onset of symptoms. Despite these obvious shortfalls, there was a statistically significant, albeit modest, impact on time to clinical recovery for patients using ivermectin to treat COVID-19. T

The FLCCC is pleased with the recent legislative developments in New Hampshire that will allow over the counter (OTC) access to ivermectin.

Treating early is imperative. Yet the TOGETHER trial studied patients where they started treatment up to eight days after the onset of symptoms.

Smith, the 51-year-old father of 3 whose wife went to court to compel a Cincinnati hospital to give him IVM as a last resort, received 13 days of ivermectin and showed improvement, until the court order was rescinded and the hospital refused to provide more IVM.

We commend the efforts of the Island of Grenada in managing to limit the spread of Covid-19 and we understand that the government is anxious to keep cases at a minimum.

We commend the efforts of the Republic of Trinidad and Tobago in mitigating the suffering of Trinidadians and Tobagonians at this trying time. FLCCC Alliance and BiRD Group Joint Statement for Trinidad and Tobago

A reexamination of the data without the earlier research continues to prove that ivermectin is effective in preventing and treating COVID-19

Joint Statement of the FLCCC & the BiRD Group on the Unethical and Questionable Methods of the Upcoming PRINCIPLE Trial.

Transcript of Dr. Kory's video message on the U.S. Deal to Give $1.2 Billion Taxpayer Dollars to Merck Instead of distributing safe, effective, inexpensive ivermectin

Read the joint statement for Namibia from the FLCCC Alliance and the BiRD Group.

The joint statement for Jamaica from the FLCCC Alliance and the BiRD Group on ivermectin as a COVID-19 treatment.

Click here to read the Letter To Indonesia from the FLCCC Alliance.

Awareness of ivermectin’s efficacy and its adoption by physicians worldwide to successfully treat COVID-19 have grown exponentially over the past several months.

We commend the tremendous efforts of the Indian central government, state governments, media personnel, doctors, nursing staff, police personnel, paramedical staff and other organisations in mitigating the suffering of Indians at this time.

The World Health Organization and National Institutes of Health now have all the data they need to recommend ivermectin to prevent and treat COVID-19. And those who want to end this pandemic now, for all countries rich and poor, should welcome that move.

Despite the rapidly increasing and diverse amounts of medical evidence supporting ivermectin as a life-saving therapy in COVID, multiple national and international health agencies – including but not limited to the World Health Organization, the European Medicines Agency, and the regulatory health agencies of all of North America and Europe – have continued to issue negative recommendations against use of ivermectin in COVID-19.

The Front Line COVID-19 Critical Care Alliance (FLCCC), a group of highly published, world-renowned critical care physicians and scholars, today praised the recent updated guidance from the All India Institute of Medical Science (AIIMS) to include ivermectin in its guidelines for the treatment of COVID-19.

WHO ignores significant data, including several large clinical trials, while claiming insufficient evidence to recommend the use of ivermectin to prevent and treat COVID-19

At a March 18, 2021 press conference, a group of medical and scientific experts convened by the Front Line COVID-19 Critical Care Alliance (FLCCC) called for action to put an end to the COVID-19 pandemic by immediately adopting policies that allow for the use of ivermectin in the prevention and treatment of COVID-19.

The FLCCC Alliance is troubled by the recently updated consumer guidance on Ivermectin from the FDA. The guidance from the FDA is misleading and has the potential to raise unwarranted concern over an important drug in the prevention and treatment of COVID-19.

On January 6, 2021, Dr. Paul Marik and Dr. Pierre Kory – founding members of the Front Line Covid-19 Critical Care Alliance (FLCCC) – along with Dr. Andrew Hill, researcher and consultant to the World Health Organization (WHO), presented their data on ivermectin before the National Institutes of Health (NIH) Treatment Guidelines Panel.